Keyhaven emerges as backer of Adelis GP-led
Nordic mid-market buyout house Adelis Equity Partners has rolled in-vitro diagnostics company SSI Diagnostica into a single-asset continuation fund.
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .Issues with signing in? Click here
Don't have an account? Register now
Nordic mid-market buyout house Adelis Equity Partners has rolled in-vitro diagnostics company SSI Diagnostica into a single-asset continuation fund.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group.Copyright PEI Media
Not for publication, email or dissemination